S07-1066 is an Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitor for Reversing AKR1C3-Mediated Drug Resistance in Cancer Treatment. S07-1066 selectively blocked AKR1C3-mediated reduction of doxorubicin (DOX) in MCF-7 transfected cell models. Furthermore, co-treatment of S07-1066 significantly synergized DOX cytotoxicity and reversed the DOX resistance in MCF-7 cells overexpressing AKR1C3. The potential synergism of S07-1066 over DOX cytotoxicity was demonstrated in vitro and in vivo.
MedKoo Cat#: 124132
Name: S07-1066
CAS#: N/A
Chemical Formula: C16H11Cl2FO2
Exact Mass: 324.0100
Molecular Weight: 325.16
Elemental Analysis: C, 59.10; H, 3.41; Cl, 21.80; F, 5.84; O, 9.84
The following data is based on the product molecular weight 325.16 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |